RPI 产品代理

COVID-19 Research

Since its opening in 2004, CBIS has made an indelible imprint on the world. CBIS researchers have developed high-tech, high-throughput methods to identify drug toxicities; they’ve devised inventive ways to synthesize the complex molecules of life; they’ve discovered how bacterial communities resist and become resistant to antibiotics; they’ve described how mistakes in protein folding occur; and they’ve advanced the methods and materials with which to grow human tissue.

Our collaborative research teams bridge disciplines and work at the frontiers of scientific knowledge, offering new ways of tackling fundamental science and developing technologies to improve lives. CBIS researchers uniquely focus on collaborative, translational research at the frontiers of life sciences, physical science, informatics, bioengineering, data modeling, bioimaging, engineering, lighting systems, architecture, business, the arts, and media technologies.

As a result of the center’s focus on both fundamental and applied research in biotechnology, new tools are being developed to delve into and better understand biology and ultimately to design new products and processes that will address key challenges and opportunities.